Loading...

Aclarion, Inc.

ACONW•NASDAQ
Healthcare
Medical - Healthcare Information Services
$0.04
$-0.00(-0.28%)

Aclarion, Inc. (ACONW) Stock Overview

Explore Aclarion, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 58.8/100

Key Financials

Market Cap20.9K
P/E Ratio-0.25
EPS (TTM)$-6.58
ROE-1.27%
Fundamental Analysis

AI Price Forecasts

1 Week$0.03
1 Month$0.00
3 Months$0.05
1 Year Target$0.01

ACONW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Aclarion, Inc. (ACONW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.25 and a market capitalization of 20.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for ACONWStats details for ACONW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ACONWAnalyst Recommendations details for ACONW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

CEO

Brent Ness

Employees

5

Headquarters

951 Mariners Island Boulevard, Broomfield, CA

Founded

1970

Frequently Asked Questions

;